Immunoreactive adrenomedullin (AM) concentration in maternal plasma during human pregnancy and AM expression in placenta

Department of Obstetrics and Gynecology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-0034, Japan.

Adrenomedullin (AM) is a novel vasorelaxant peptide, isolated from human pheochromocytoma. Although AM may be involved in the regulation of the cardiovascular system, a number of other mechanisms are also involved. The present study was undertaken to confirm the presence of AM in human maternal circulation and in placental function during pregnancy. Immunoreactive (ir) AM concentrations in maternal plasma were 3.4+/-0.7fmol/ml (mean+/-s.e. m.) in the first trimester, 3.3+/-1.1fmol/ml in the second trimester, 7.3+/-2.8fmol/ml in the third trimester, 4.1+/-1.9fmol/ml in early puerperium and 3.0+/-0.4fmol/ml in non-pregnant periods; the concentration in the third trimester was significantly greater than those in other periods. Plasma concentrations of estradiol (E(2)), progesterone, human placental lactogen (hPL) and human chorionic gonadotropin (hCG) were also measured, using RIA kits. Significant correlations have been demonstrated between the concentrations of irAM and those of E(2), progesterone and hPL. We therefore examined the expression of AM within the placental tissues using immunohistochemistry and northern blot analysis in order to demonstrate a correlation between the presence of AM in the placenta and maternal plasma. Using immunohistochemistry, we detected AM in the amnion at term and the expression of AM mRNA in human placental tissues using cloned human (h) AM complementary DNA as a probe. This study demonstrates the immunoreactivity of human hAM in maternal plasma during pregnancy, and suggests that hAM in maternal plasma is generated partly from placental tissue.

This article has been cited by other articles:

				H.W.F. van Eijndhoven, R. Aardenburg, M.E.A. Spaanderman, J.G.R. De Mey, and L.L.H. Peeters Pregnancy Enhances the Prejunctional Vasodilator Response to Adrenomedullin in Selective Regions of the Arterial Bed of Wistar Rats Reproductive Sciences, December 1, 2007; 14(8): 771 - 779. [Abstract] [PDF]

				M. Chauhan, G. R. Ross, U. Yallampalli, and C. Yallampalli Adrenomedullin-2, a Novel Calcitonin/Calcitonin-Gene-Related Peptide Family Peptide, Relaxes Rat Mesenteric Artery: Influence of Pregnancy Endocrinology, April 1, 2007; 148(4): 1727 - 1735. [Abstract] [Full Text] [PDF]

				E. Marinoni, C. Zacharopoulou, A. Di Rocco, C. Letizia, M. Moscarini, and R. Di Iorio Effect of Betamethasone In Vivo on Placental Adrenomedullin in Human Pregnancy Reproductive Sciences, September 1, 2006; 13(6): 418 - 424. [Abstract] [PDF]

				A. Al-Ghafra, N.M. Gude, S.P. Brennecke, and R.G. King Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia Mol. Hum. Reprod., March 1, 2006; 12(3): 181 - 186. [Abstract] [Full Text] [PDF]

				Y. Hayashi, H. Ueyama, T. Mashimo, K. Kangawa, and N. Minamino Circulating Mature Adrenomedullin Is Related to Blood Volume in Full-Term Pregnancy Anesth. Analg., December 1, 2005; 101(6): 1816 - 1820. [Abstract] [Full Text] [PDF]

				X. Zhang, K. E. Green, C. Yallampalli, and Y. L. Dong Adrenomedullin Enhances Invasion by Trophoblast Cell Lines Biol Reprod, October 1, 2005; 73(4): 619 - 626. [Abstract] [Full Text] [PDF]

				J. Penchalaneni, S. J. Wimalawansa, and C. Yallampalli Adrenomedullin Antagonist Treatment During Early Gestation in Rats Causes Fetoplacental Growth Restriction Through Apoptosis Biol Reprod, November 1, 2004; 71(5): 1475 - 1483. [Abstract] [Full Text] [PDF]

				R. J. Gratton, M. Gluszynski, D. M. Mazzuca, K. Nygard, and V. K. M. Han Adrenomedullin Messenger Ribonucleic Acid Expression in the Placentae of Normal and Preeclamptic Pregnancies J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6048 - 6055. [Abstract] [Full Text] [PDF]

				H. Li, J. Dakour, S. Kaufman, L. J. Guilbert, B. Winkler-Lowen, and D. W. Morrish Adrenomedullin Is Decreased in Preeclampsia Because of Failed Response to Epidermal Growth Factor and Impaired Syncytialization Hypertension, November 1, 2003; 42(5): 895 - 900. [Abstract] [Full Text] [PDF]

				L.L. Nikitenko, N.S. Brown, D.M. Smith, I.Z. MacKenzie, R. Bicknell, and M.C.P. Rees Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus Mol. Hum. Reprod., July 1, 2001; 7(7): 655 - 664. [Abstract] [Full Text] [PDF]